The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
المؤلفون المشاركون
Li, Qian
Li, Cailan
Xu, Jiamin
Wu, Wenzhen
Wu, Yuling
Xie, Jianhui
Yang, Xiaobo
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-15، 15ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-11-17
دولة النشر
مصر
عدد الصفحات
15
التخصصات الرئيسية
الملخص EN
Objective.
Compound Danshen dripping pill (CDDP) is a well-known Chinese patent medicine, which is commonly used for the treatment of coronary heart disease (CHD) in China.
This study is aimed at systematically assessing the clinical efficacy of CDDP for CHD patients.
Methods.
Eight databases were retrieved for eligible research studies from the founding date to April 20, 2020.
Risk ratio (RR) was used to assess major adverse cardiac events (MACE) and adverse reactions, and mean difference (MD) was adopted to evaluate the hemorheology and blood lipid indexes, vascular endothelial function, cardiac function, and inflammation.
Result.
Twenty randomized controlled trials involving 2574 participants with CHD were included.
The results indicated that, compared with percutaneous coronary intervention (PCI) alone, the combination of CDDP with PCI treatment remarkably reduced MACE (RR = 0.53, 95% confidence interval (CI) (0.44, 0.65), P<0.00001).
Moreover, hemorheology and blood lipid parameters and inflammatory mediators of CHD patients were also dramatically mitigated after the combined therapy P<0.01.
In addition, vascular endothelial function and cardiac function were prominently improved by this combination P<0.001.
However, there was no significant difference in adverse reactions between the two groups P>0.05.
Conclusion.
Evidence from the meta-analysis demonstrated that CDDP combined with PCI treatment prominently reduced the incidence of MACE, improved cardiovascular functions, and inhibited inflammation in CHD patients.
Therefore, CDDP combined with PCI treatment could be an effective and safe therapeutic method for CHD patients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Li, Cailan& Li, Qian& Xu, Jiamin& Wu, Wenzhen& Wu, Yuling& Xie, Jianhui…[et al.]. 2020. The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease. Evidence-Based Complementary and Alternative Medicine،Vol. 2020, no. 2020, pp.1-15.
https://search.emarefa.net/detail/BIM-1156391
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Li, Cailan…[et al.]. The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease. Evidence-Based Complementary and Alternative Medicine No. 2020 (2020), pp.1-15.
https://search.emarefa.net/detail/BIM-1156391
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Li, Cailan& Li, Qian& Xu, Jiamin& Wu, Wenzhen& Wu, Yuling& Xie, Jianhui…[et al.]. The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease. Evidence-Based Complementary and Alternative Medicine. 2020. Vol. 2020, no. 2020, pp.1-15.
https://search.emarefa.net/detail/BIM-1156391
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1156391
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر